Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial. Sadeghipour P, Talasaz AH, Rashidi F, et al. JAMA. 2021;325(16):1620-1630.

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245733/
http://dx.doi.org/10.1016/j.jemermed.2022.06.019
_version_ 1784738807955849216
collection PubMed
description
format Online
Article
Text
id pubmed-9245733
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-92457332022-07-01 Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial. Sadeghipour P, Talasaz AH, Rashidi F, et al. JAMA. 2021;325(16):1620-1630. J Emerg Med Article Published by Elsevier Inc. 2022-06 2022-06-30 /pmc/articles/PMC9245733/ http://dx.doi.org/10.1016/j.jemermed.2022.06.019 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial. Sadeghipour P, Talasaz AH, Rashidi F, et al. JAMA. 2021;325(16):1620-1630.
title Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial. Sadeghipour P, Talasaz AH, Rashidi F, et al. JAMA. 2021;325(16):1620-1630.
title_full Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial. Sadeghipour P, Talasaz AH, Rashidi F, et al. JAMA. 2021;325(16):1620-1630.
title_fullStr Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial. Sadeghipour P, Talasaz AH, Rashidi F, et al. JAMA. 2021;325(16):1620-1630.
title_full_unstemmed Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial. Sadeghipour P, Talasaz AH, Rashidi F, et al. JAMA. 2021;325(16):1620-1630.
title_short Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial. Sadeghipour P, Talasaz AH, Rashidi F, et al. JAMA. 2021;325(16):1620-1630.
title_sort effect of intermediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among patients with covid-19 admitted to the intensive care unit: the inspiration randomized clinical trial. sadeghipour p, talasaz ah, rashidi f, et al. jama. 2021;325(16):1620-1630.
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245733/
http://dx.doi.org/10.1016/j.jemermed.2022.06.019

Ejemplares similares